Skip to main content
Caplight Logo









Zhongze Therapeutics

Zhongze Therapeutics

Private
ShanghaiHealthcare & Life Scienceshttps://zhongzetherapeutics.com/

Last Round

Pre Seed

Sep 30, 2021

Total Funding Raised

$10M

Company Overview

Zhongze Therapeutics is a clinical-stage biotechnology company that focuses on the discovery, development, and commercialization of innovative therapies for psychiatric and neurological disorders.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Mental Health, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

biotechnologyCNS therapeuticscentral nervous systemdrug discoveryclinical-stage biotechschizophrenia treatmentprecision neurologyneuroplasticitysmall moleculeclinical trialsbiotech startupdrug licensingmental healthpsychiatric disordersneurological disorders

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Zhongze Therapeutics Comparables

Compare Zhongze Therapeutics with similar companies based on industry and business-model similarity.

Zhongze Therapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Viage Therapeutics
80%
NeuShen Therapeutics
79%
Neurosterix
78%

Zhongze Therapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Pre SeedSep 30, 2021

Zhongze Therapeutics Investors

Notable investors and investment history

Zhongze Therapeutics investors
InvestorRounds
Cenova CapitalPre Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 30, 2021

    $10M round led by Cenova Capital

Zhongze Therapeutics Filings

Explore SEC and related filing metadata, where available.

Zhongze Therapeutics filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Zhongze Therapeutics's valuation, stock price, and market status.

Is Zhongze Therapeutics a public or private company?

Zhongze Therapeutics is a private company.

What is the current stock price of Zhongze Therapeutics?

Zhongze Therapeutics is a private company with no public stock price. Caplight tracks Zhongze Therapeutics's secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is Zhongze Therapeutics worth (valuation)?

Valuation information for Zhongze Therapeutics is not publicly available.

Can I buy Zhongze Therapeutics stock?

Zhongze Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Zhongze Therapeutics's last funding round?

Zhongze Therapeutics's most recent funding round was Pre Seed on September 30, 2021.

Who are the main investors in Zhongze Therapeutics?

Key investors in Zhongze Therapeutics include Cenova Capital.

Will Zhongze Therapeutics IPO soon?

No public IPO plans have been announced for Zhongze Therapeutics.

How can I track Zhongze Therapeutics secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Zhongze Therapeutics's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersShanghai
Year Founded2021
Last FundingSep 30, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?